Original Article: Low Regulatory Volume Decrease Rate in Platelets from Ischemic Patients: A Possible Role for Hepoxilin A₃ in Thrombogenicity

References

• Mehta J. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs. JAMA 1993; 249: 2818–2823
   Google Scholar
• Fuster V, Badimon L, Badimon J J., Chesebro J H. The pathogenesis of coronary artery disease and acute coronary syndromes. N Eng J Med 1992; 326: 242–250
   PubMed Web of Science ®Google Scholar
• Rousseau G, Hebert D, Libersan D, Khalil A, St-Jean G, Latour J-G. Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogs. Am Heart J 1993; 125: 1553–1563
   PubMed Web of Science ®Google Scholar
• Wright L, Homans D C., Laxson D D., Dai X-Z, Bache R J. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels. J Am Coll Cardiol 1992; 19: 687–693
   PubMed Web of Science ®Google Scholar
• Adam P C., Fuster V, Badimon L, Badimon J J., Chesebro J H. Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategies. Am J Cardiol 1987; 60: 9G–16G
   Web of Science ®Google Scholar
• Gotoh K, Minamino T, Katoh O, et al. The role of intracoronary thrombus in unstable angina: angioscopic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation 1988; 77: 526–534
   PubMed Web of Science ®Google Scholar
• Weinberger I, Fuchs J, Davidson E, Rotenberg Z. Circulating aggregated platelets, number of platelets per aggregate, and platelet size during acute myocardial infarction. Am J Cardiol 1992; 70: 981–983
   PubMed Web of Science ®Google Scholar
• Nash G B. Blood rheology and ischaemia. Eye 1991; 5: 151–158
   PubMedGoogle Scholar
• Badimon L, Chesebro J H., Badimon J J. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992; 86(III), 74-III-85
   Google Scholar
• Merhi Y, Lam J. Y.T., Lacoste L L., Latour J-G, Guidoin R., Waters D. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Arteriosclerosis and Thrombosis 1993; 13: 951–957
   PubMedGoogle Scholar
• Brown C H., Leverett L B., Lewis C W., Alfrey C P., Hellmus J D. Morphological, biochemical, and functional changes in human platelets subjected to shear stress. J Lab Clin Med 1975; 86: 462–471
   PubMed Web of Science ®Google Scholar
• Moritz M W., Reimers R C., Baker R K., Sutera S P., Joist J H. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress. J Lab Clin Med 1983; 101: 537–544
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, McIntire L V., Hall E R., Wu K K. The stimulation of arachidonic acid metabolism in human platelets by hydrodynamic stresses. Biochim Biophys Acta 1988; 958: 108–115
   PubMedGoogle Scholar
• O'Brien J R., Salmon G P. Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long rebleeding time in von Willebrand disease. Blood 1987; 70: 1354–1361
   PubMed Web of Science ®Google Scholar
• Hellums J D., Peterson D M., Stathopoulos N A., Moake J L., Giorgio T D. Studies on the mechanisms of shear-induced platelet activation. Cerebral Ischemia and Hemorheology, AW Hartmann. Springer-Verlag, Berlin-Heidelberg 1987; 80–89
   Google Scholar
• Fitzgerald D J., Roy L, Catella F, Fitzgerald G A. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–989
   PubMed Web of Science ®Google Scholar
• Sinzinger H, Wasinger T. Eicosanoids in the local regulation of haemostasis. Ziet Kardiol 1989; 78: 30–34
   PubMedGoogle Scholar
• De Clerck F F., Janssen P. A.J. Amplification mechanisms in platelet activation and arterial thrombosis. J Hypertension 1990; 8: S87–S93
   Web of Science ®Google Scholar
• Pace-Asciak C R., Asorta S. Biosynthesis, catabolism and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radical Biology and Medicine 1989; 7: 409–433
   PubMed Web of Science ®Google Scholar
• Pace-Asciak C R. Hepoxilins. Gen Pharmac 1993; 24: 805–810
   PubMedGoogle Scholar
• Margalit A, Livne A A. Lipoxygenase product controls the regulatory volume decrease of human platelets. Platelets 1991; 2: 207–214
   PubMedGoogle Scholar
• Margalit A, Sofer Y, Grossman S, Reynaud D, Pace-Asciak C R., Livne A A., Hepoxilin A. is the endogenous lipid mediator opposing hypotonic swelling of human intact platelets. Proc Natl Acad Sci USA 1993; 90: 2589–2592
   PubMed Web of Science ®Google Scholar
• Margalit A, Livne A A. Human platelets exposed to mechanical stresses express a potent lipoxygenase product. Thromb Haemostas 1992; 68: 589–594
   PubMed Web of Science ®Google Scholar
• Margalit A, Livne A A., Funder J, Granot Y. Initiation of RVD response in human platelets: mechanical-biochemical transduction involves pertussis toxin sensitive G-protein and phospholipase A2. J Membrane Biol 1993; 136: 304–311
   Web of Science ®Google Scholar
• Strauss A L., Schaberle W, Rieger H, Roth F-J. Use of duplex scanning in the diagnosis of arteria profunda femoris stenosis. J Vasc Surg 1991; 13: 698–704
   PubMed Web of Science ®Google Scholar
• Strony J, Beaudoin A, Brands D, Adelman B. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 1993; 265: H1787–H1796
   PubMed Web of Science ®Google Scholar
• Margalit A, Granot Y, Endogenous Hepoxilin A. produced under short duration of high shear-stress, inhibits thrombin-induced aggregation in human platelets. Biochim Biophys Acta 1994; 1990: 173–176
   Google Scholar
• Elmfeldt D, Wilhemsen L, Tibblin G, Vedin J A., Wilhelmsson C-E, Bengtsson C. Registration of myocardial infarction in the city of Goteborg, Sweden. A community study. J Chron Dis 1975; 28: 173–186
   PubMedGoogle Scholar
• Arita H, Nakano T, Hanasaki K. Thromboxane A2: Its generation and role in platelet activation. Prog Lipid Res 1989; 28: 273–301
   PubMed Web of Science ®Google Scholar
• Schafer A I., Cooper B, O'Hara D, Handin R I. Identification of platelet receptors for prostaglandin I, and D. J Biol Chem 1979; 254: 2914–2917
   PubMed Web of Science ®Google Scholar
• Golino P, Maroko P R., Carew T E. Efficiency of platelet depletion in counteracting the detrimental effect of hypercholesterolemia on infarct size and no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation 1987; 76: 173–180
   PubMed Web of Science ®Google Scholar
• Sinzinger H, Kaliman J, O'Grady J. Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. A J Hematol 1991; 36: 202–205
   PubMed Web of Science ®Google Scholar
• Pace-Asciak C R., Matrin J M. Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets. 1984; 16: 173–180, j
   Google Scholar
• Nathan M H., Pek S B. Lipoxygenase-generated icosanoids inhibit glucose-induced insulin release from rat islets. Prostagl Leukot Essent Fatty Acids 1990; 40: 21–25
   PubMed Web of Science ®Google Scholar
• Pace-Asciak C R., Matrin J M., Lee S-P. Appearance of prostaglandins, thromboxane B2 and hepoxilin A3 in the circulation of the normal and diabetic (BB) rat after arachidonic acid administration—correlation with plasma insulin. Biochem Cell Biol 1988; 66: 901–909
   PubMed Web of Science ®Google Scholar
• Harker L A., Malpass T W., Branson H E., Hessel E A., Slichter S J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective a-granule release. Blood 1980; 56: 824–834
   PubMed Web of Science ®Google Scholar